Wick Capital Partners »

Regeneron Pharmaceuticals shares owned by Wick Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Wick Capital Partners from 13F filings

Historical chart of Wick Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Wick Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Wick Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $336k 657 510.76

More positions owned by Wick Capital Partners

Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Total Stk Mkt (VTI)
Blackrock Etf Trust Ii Ishares Lrg Cap (IVVB)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Goldman Cap Buff (GBXA)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr Ibonds 27 Etf (IBDS)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Ishares Core Msci Emkt (IEMG)
J P Morgan Exchange Traded F Hedged Equity La (HELO)
Ishares Tr Ibonds Dec2026 (IBDR)
Goldman Sachs Etf Tr S&p 500 Premium (GPIX)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)

View all positions for Wick Capital Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals